Endonovo Therapeutics, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2019 | $15.4M | $3.8M | $58.5K |
| Jun 2019 | $20.4M | $4.1M | $547.5K |
| Sep 2019 | $20.0M | $3.4M | $5.0K |
| Dec 2019 | $23.8M | $3.3M | $18.9K |
| Mar 2020 | $14.2M | $3.1M | $178 |
| Jun 2020 | $15.1M | $2.9M | $5.3K |
| Sep 2020 | $15.5M | $2.7M | $2.6K |
| Dec 2020 | $17.0M | $2.6M | $13.4K |
| Mar 2021 | $18.5M | $2.5M | $86.0K |
| Jun 2021 | $19.3M | $2.3M | $8.5K |
| Sep 2021 | $20.4M | $2.1M | $5.7K |
| Dec 2021 | $17.8M | $2.0M | $85.9K |
| Mar 2022 | $19.9M | $1.8M | $60.0K |
| Jun 2022 | $20.8M | $1.6M | — |
| Sep 2022 | $21.1M | $1.5M | $23.1K |
| Dec 2022 | $33.5M | $1.3M | $98 |
| Mar 2023 | $25.6M | $1.2M | $10.9K |
| Jun 2023 | $23.2M | $1.0M | $32.6K |
| Sep 2023 | $23.8M | $815.8K | $0 |